These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 14606290

  • 1. [Kidney failure, proteinuria, and diabetic nephropathy].
    Collart F.
    Rev Med Brux; 2003 Sep; 24(4):A257-62. PubMed ID: 14606290
    [Abstract] [Full Text] [Related]

  • 2. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L, Kocks MJ, Laverman GD, Navis G.
    Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. ACE inhibitors versus angiotensin receptor blockers in diabetic nephropathy: is there a winner?
    Lewis EJ, Lewis JB.
    J Am Soc Nephrol; 2004 May; 15(5):1358-60. PubMed ID: 15100380
    [No Abstract] [Full Text] [Related]

  • 5. Angiotensin receptor blockers do not have an advantage over angiotensin-converting inhibitors [corrected].
    Harman-Boehm I.
    Isr Med Assoc J; 2004 May; 6(5):296-8. PubMed ID: 15151373
    [No Abstract] [Full Text] [Related]

  • 6. [The early diagnosis of kidney failure in diabetic patients and the new developments in its treatment].
    Eliseev OM.
    Ter Arkh; 1995 May; 67(4):66-9. PubMed ID: 7784984
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Determinants of progression from microalbuminuria to proteinuria in patients who have type 1 diabetes and are treated with angiotensin-converting enzyme inhibitors.
    Ficociello LH, Perkins BA, Silva KH, Finkelstein DM, Ignatowska-Switalska H, Gaciong Z, Cupples LA, Aschengrau A, Warram JH, Krolewski AS.
    Clin J Am Soc Nephrol; 2007 May; 2(3):461-9. PubMed ID: 17699452
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Dual blockade of the renin-angiotensin system in diabetic nephropathy.
    Wade VL, Gleason BL.
    Ann Pharmacother; 2004 May; 38(7-8):1278-82. PubMed ID: 15187210
    [Abstract] [Full Text] [Related]

  • 11. Benazepril and the kidney: new indication. No better than the other ACE inhibitors.
    Prescrire Int; 1998 Dec; 7(38):174-6. PubMed ID: 10848048
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Proteinuria, a modifiable risk factor: angiotensin converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs).
    Dykeman-Sharpe J.
    CANNT J; 2003 Dec; 13(4):34-6; quiz 37-8. PubMed ID: 14753101
    [Abstract] [Full Text] [Related]

  • 14. Angiotensin II receptor blockade in diabetic nephropathy.
    Andersen S.
    Dan Med Bull; 2004 Aug; 51(3):274-94. PubMed ID: 16009059
    [No Abstract] [Full Text] [Related]

  • 15. [Clinical studies on chronic diabetic nephropathy and recent data concerning prevention of risks of nephropathy and cardiovascular diseases].
    Esnault V.
    Nephrol Ther; 2006 May; 2 Suppl 3():S193-6. PubMed ID: 17370850
    [Abstract] [Full Text] [Related]

  • 16. Effects of different antihypertensive drugs on human diabetic proteinuria.
    Weidmann P, Boehlen LM, de Courten M.
    Nephrol Dial Transplant; 1993 May; 8(7):582-4. PubMed ID: 8396739
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Screening and treatment of diabetic renal disease.
    Clement JD, Cottiero RA.
    Med Health R I; 1998 Nov; 81(11):348-9. PubMed ID: 15580788
    [No Abstract] [Full Text] [Related]

  • 19. Toward better renoprotection: lessons from angiotensin receptor blockers.
    Miyata T, Takizawa S.
    Hemodial Int; 2007 Apr; 11(2):164-8. PubMed ID: 17403166
    [Abstract] [Full Text] [Related]

  • 20. Losartan in diabetic nephropathy.
    Perico N, Ruggenenti P, Remuzzi G.
    Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):473-83. PubMed ID: 15225108
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.